Earnings in First Quarter 2008 at record levels: 26.5% pre-tax sales yield and 36.1% rate of growth

--------------------------------------------------------------------------------
ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for
the content of this announcement.
--------------------------------------------------------------------------------

Berlin (euro adhoc) - Sales by listed medical device manufacturer WORLD OF
MEDICINE soared by 36.1% in the first quarter of 2008, to TE10,791. "At that
level, total sales eclipsed even the normally stronger fourth quarter of the
prior year," says Peter P. Wiest, CEO of WORLD OF MEDICINE. "We have reaped the
benefits from the relatively recent product launches of 2007. In particular,
the Medical-HD® camera for minimally invasive procedures performed extremely
well in Europe." The pre-tax sales yield for the first 3 months of 2008
achieved a record value of 26.5%.

| |Q1/2008 |Q1/2007 |Change
|
|Sales |TE10,791 |TE7,929 |+ 36.1 %
|
|EBT |TE2,863 |TE1,167 |+TE1,696
|
|Pre-tax sales yield|26.5 % |14.7 % |+ 80.3 %
|
|Earnings per share |E0.22 |E0.09 |> 100 %

Based on Management Board estimates for the remainder of the year, the
opportunities in Europe and Asia must be weighed with the risk of further
weakening in the US market. WORLD OF MEDICINE is therefore projecting continued
steady business development, and is adhering to the annual targets set for
2008: an increase in sales equal to market growth of 7%, and a pre-tax sales
yield of 11%. The Management Board, however, may pursue further investment in
additional projects that hold promise for future growth opportunities.

The entire Quarterly Financial Report for the first 3 months of 2008 is
available at:
www.world-of-medicine.com/wsc/pdf/wom/en/qr_3monthreport_2008_wom.pdf

Today at 11:00 a.m. CET, a telephone conference on the quarterly figures is
scheduled for analysts, investors and press representatives. To participate,
please contact the Company directly.

WORLD OF MEDICINE and its technologies are paving the way in Minimally Invasive
Surgery - or MIS( for short. This approach includes safe and gentle surgical
procedures conducted not through major incisions, but through keyhole or
puncture incisions. The Company is the global market leader in a niche of this
future market.

Further inquiry note:
Stefanie Gehrke
Tel.: +49 (0)30 399 81 566
E-Mail: stefanie.gehrke@womcorp.com

end of announcement euro adhoc
--------------------------------------------------------------------------------

emitter: W.O.M. World of Medicine AG
Salzufer 8
D-10587 Berlin
phone: +49 (0)30 399 81-500
FAX: +49 (0)30 399 81-551
mail: info.berlin@womcorp.com
WWW: http://www.world-of-medicine.com
sector: Pharmaceuticals
ISIN: DE0006637390
indexes: CDAX, Prime All Share, Technologie All Share
stockmarkets: regulated dealing/prime standard: Börse Frankfurt, free trade:
Börse Berlin, Börse Hamburg, Börse Stuttgart, Börse Düsseldorf,
Börse München
language: English

OTS-ORIGINALTEXT PRESSEAUSSENDUNG UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS - WWW.OTS.AT | CNE

print